HTDI 2022

Event Details

  • Start Date 12/15/2022
  • Start Time 08:30
  • End Time 00:00
Topics Speakers Time Venue
SUPERFICIAL VENOUS 08.00-08.57 Session 1
EDITED VIDEO CASE 08.01
High intensity focused ultrasound (HIFU) for the treatment of varicose veins and venous leg ulcers 08.06
Factors influencing recurrences after radiofrequency thermal ablation 08.12
Randomized clinical trial comparing cyanoacrylate glue closure with thermal ablation and surgical stripping 08.18
Tandem vein tumescent during polidocanol endovenous microfoam ablation of saphenous veins: a novel technique to expand indications and limit product volume and results 08.24
Sclerotherapy with dense polidocanol foam in saphenous and tributary veins. Long-term results 08.30
Discussion 08.36-08.44
KEYNOTE LECTURE 08.45-08.57
PELVIC VENOUS DISORDERS 09.00-10.07 Session 2
EDITED VIDEO CASE 09.01
Pelvic congestion syndrome - diagnosis and treatment strategies 09.06
Gonadal vein and pelvic venous reservoir embolization 09.12
Optimal technique for sclerotherapy of vulval varicosities 09.18
Embolization techniques for erectile dysfunction 09.24
Open surgery is still the gold standard for nutcracker syndrome 09.30
Outcomes of left renal vein stenting in patients with nutcracker syndrome 09.36
Discussion 09.42-09.54
KEYNOTE LECTURE 09.55-10.07
DEEP VEIN THROMBOSIS 10.10-11.07 Session 3
EDITED VIDEO CASE 10.11
Cather directed interventions for pulmonary embolism 10.16
Venous thromboembolization pharmacological treatment: what is new in 2024? 10.22
Thrombolysis and thromboaspiration for DVT 10.28
Computed assisted vacuum thrombectomy for DVT 10.34
Anatomical disease classification to optimize decision making and outcomes for deep venous recanalization procedures 10.40
Discussion 10.46-10.54
KEYNOTE LECTURE 10.55-11.07
COMPRESSIVE VENOUS DISEASE 11.10-12.17 Session 4
EDITED VIDEO CASE 11.11
Technical approach to venous stenting in non-thrombotic iliac vein lesions patient 11.16
The role of IVUS in non-thrombotic iliac vein lesions 11.22
Endovascular treatment of venous occlusion: from May-Thurner to hypoplasia of the IVC 11.28
When and how to manage patients presenting with acute DVT and underlying culprit lesion 11.34
The need of a new dedicated caval stent 11.40
Discussion 11.46-11.59
KEYNOTE LECTURE 12.00-12.12
POST-THROMBOTIC SYNDROME 12.15-13.12 Session 5
EDITED VIDEO CASE 12.16
Primary and invasive ilio-caval tumors – what do the current vascular techniques have to offer in this challenging cases? 12.21
Different approaches to improve the inflow in PTS patients 12.27
Quality of life after stenting for iliofemoral venous obstruction: a randomised controlled trial 12.33
Different stents for different anatomies 12.39
Discussion 12.45-12.54
KEYNOTE LECTURE 12.55-13.07